Leases

3 Months Ended

Dec. 31, 2022

11. LEASES

Leases

The Company leases office and research and development facility leases under non-cancelable operating leases for various

terms through 2030. Certain lease agreements include renewal options, rent abatement periods, and rental increases throughout the

term. As of December 31, 2022, the weighted-average remaining lease term for the Company’s operating leases was 4.59 years and the weighted-average discount rate was 3.3%.

As of December 31, 2022, the Company had operating ROU assets of $5.0 million. As of December 31, 2022, total operating lease liabilities of $6.0 million were comprised of current lease liabilities of $2.1 million and non-current lease liabilities of $3.9 million. As of September 30, 2022, the Company had operating ROU assets of $5.2 million. As of September 30, 2022, total operating lease liabilities of $6.2 million were comprised of current lease liabilities of $2.1 million and non-current lease liabilities of $4.1 million.

The Company recognized $0.5 million and $0.6 million of operating lease costs for the three months ended December 31, 2022 and 2021, respectively. Operating lease costs are included within cost of revenue, selling and marketing, research and development, and general and administrative expenses, dependent upon the nature and use of the ROU asset, in the Company’s condensed consolidated statement of operations and other comprehensive income.

The Company paid $0.6 million in operating cash flows for operating leases in the three months ended December 31, 2022.

Maturities of operating lease liabilities as of December 31, 2022 were as follows (amounts shown in thousands):


	Operating leases
2023 - remaining	1,678
2024	1,718
2025	629
2026	620
2027	625
2028	419
Thereafter	583
Total lease payments	6,272
Less: amount representing interest	(281)
Present value of future lease payments	$	5,991